Loading...
Loading...
LMDX| Name | Value |
|---|---|
| Revenues | 126.4M |
| Cost of Revenue | 76.4M |
| Gross Profit | 50.0M |
| Operating Expense | 81.5M |
| Operating I/L | -31.4M |
| Other Income/Expense | -22.5M |
| Interest Income | 5.4M |
| Pretax | -54.0M |
| Income Tax Expense | 2.2M |
| Net Income/Loss | -56.2M |
LumiraDx Limited is a point of care diagnostics company that manufactures and commercializes a diagnostic platform supporting various tests with lab comparable performance at the point of care. The company offers approximately 30 tests covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed across various healthcare settings to screen, diagnose, and monitor wellness and disease. LumiraDx generates revenue by selling its diagnostic platform and tests to governments, healthcare institutions, laboratories, urgent care facilities, physician offices, pharmacies, schools, and workplaces.
